Marked variability in hepatic expression of cytochromes CYP7A1 and CYP27A1 as compared to cerebral CYP46A1. Lessons from a dietary study with omega 3 fatty acids in hamsters

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 6, 2010, Pages 674-681

  Mast, Natalia ^a   Shafaati, Marjan ^d   Zaman, Wahiduz ^b   Zheng, Wenchao ^a   Prusak, Deborah ^c   Wood, Thomas ^c   Ansari, G A S ^c   Lövgren Sandblom, Anita ^d   Olin, Maria ^d   Bjorkhem, Ingemar ^d   Pikuleva, Irina ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

American Heart Association; Brain; Cholesterol turnover; CYP27A1; CYP46A1; CYP7A1; Dietary guidelines; Fish oil; n 3 polyunsaturated fatty acids

Indexed keywords

CHOLESTANETRIOL 26 MONOOXYGENASE; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL DERIVATIVE; CYTOCHROME P450; CYTOCHROME P450 46A1; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LATHOSTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAT INTAKE; HAMSTER; LIPID BLOOD LEVEL; LIPID BRAIN LEVEL; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; CRICETINAE; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; FATTY ACIDS, OMEGA-3; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; ISOENZYMES; LIVER; MALE; MESOCRICETUS; MICROSOMES, LIVER;

CRICETINAE; MESOCRICETUS AURATUS;

EID: 77950629442     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2010.03.005     Document Type: Article

References (77)

1. Benatti P., Peluso G., Nicolai R., and Calvani M. Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J. Am. Coll. Nutr. 23 (2004) 281-302
2. Kris-Etherton P.M., Taylor D.S., Yu-Poth S., Huth P., Moriarty K., Fishell V., Hargrove R.L., Zhao G., and Etherton T.D. Polyunsaturated fatty acids in the food chain in the United States. Am. J. Clin. Nutr. 71 (2000) 179S-188S
3. Simopoulos A.P. Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins Leukot. Essent. Fatty Acids 60 (1999) 421-429
4. Jump D.B. The biochemistry of n-3 polyunsaturated fatty acids. J. Biol. Chem. 277 (2002) 8755-8758
5. Lapillonne A., Clarke S.D., and Heird W.C. Plausible mechanisms for effects of long-chain polyunsaturated fatty acids on growth. J. Pediatr. 143 (2003) S9-S16
6. Demaison L., and Moreau D. Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action. Cell. Mol. Life Sci. 59 (2002) 463-477
7. Morise A., Serougne C., Gripois D., Blouquit M.F., Lutton C., and Hermier D. Effects of dietary alpha linolenic acid on cholesterol metabolism in male and female hamsters of the LPN strain. J. Nutr. Biochem. 15 (2004) 51-61
8. Pikuleva I.A. Cholesterol-metabolizing cytochromes P450: implications for cholesterol lowering. Expert Opin. Drug Metab. Toxicol. 4 (2008) 1403-1414
9. Myant N.B., and Mitropoulos K.A. Cholesterol 7a-hydroxylase. J. Lipid Res. 18 (1977) 135-153
10. Pullinger C.R., Eng C., Salen G., Shefer S., Batta A.K., Erickson S.K., Verhagen A., Rivera C.R., Mulvihill S.J., Malloy M.J., and Kane J.P. Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J. Clin. Invest. 110 (2002) 109-117
11. 3 by a cytochrome P-450 from rabbit liver mitochondria. Biochem. J. 252 (1988) 207-213
12. Wikvall K. Hydroxylations in biosynthesis of bile acids. Isolation of a cytochrome P-450 from rabbit liver mitochondria catalyzing 26-hydroxylation of C27-steroids. J. Biol. Chem. 259 (1984) 3800-3804
13. Usui E., Noshiro M., Ohyama Y., and Okuda K. Unique property of liver mitochondrial P450 to catalyze the two physiologically important reactions involved in both cholesterol catabolism and vitamin D activation. FEBS Lett. 274 (1990) 175-177
14. Bjorkhem I., Boberg K.M., and Leitersdorf E. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: Scriver A.L., Beaudet A.L., Sly W.S., Valle D., and Childs B. (Eds). The Metabolic and Molecular Bases of Inherited Disease (1995), McGraw-Hill, New York 2073-2099
15. Bjorkhem I., Lutjohann D., Diczfalusy U., Stahle L., Ahlborg G., and Wahren J. Cholesterol homeostasis in human brain: turnover of 24 S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 39 (1998) 1594-1600
16. Lutjohann D., Breuer O., Ahlborg G., Nennesmo I., Siden A., Diczfalusy U., and Bjorkhem I. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24 S-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 9799-9804
17. Lund E.G., Guileyardo J.M., and Russell D.W. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7238-7243
18. Kotti T.J., Ramirez D.M., Pfeiffer B.E., Huber K.M., and Russell D.W. Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3869-3874
19. Bjorkhem I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J. Intern. Med. 260 (2006) 493-508
20. Hudry E., Van Dam D., Kulik W., De Deyn P.P., Stet F.S., Ahouansou O., Benraiss A., Delacourte A., Bougneres P., Aubourg P., and Cartier N. Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease. Mol. Ther. 18 (2010) 44-53
21. Bjorkhem I., Cedazo-Minguez A., Leoni V., and Meaney S. Oxysterols and neurodegenerative diseases. Mol. Aspects Med. 30 (2009) 171-179
22. Kris-Etherton P.M., and Dietschy J. Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors: human and animal studies. Am. J. Clin. Nutr. 65 (1997) 1590S-1596S
23. Nistor A., Bulla A., Filip D.A., and Radu A. The hyperlipidemic hamster as a model of experimental atherosclerosis. Atherosclerosis 68 (1987) 159-173
24. Harris R.B. Appropriate animal models for clinical studies. Ann. N. Y. Acad. Sci. 819 (1997) 155-168
25. Harris W.S. N-3 fatty acids and serum lipoproteins: animal studies. Am. J. Clin. Nutr. 65 (1997) 1611S-1616S
26. Yoshida H., Ikeda I., Tomooka M., Mawatari M., Imaizumi K., Seto A., and Tsuji H. Effect of dietary seal and fish oils on lipid metabolism in hamsters. J. Nutr. Sci. Vitaminol. (Tokyo) 47 (2001) 242-247
27. Spady D.K., Horton J.D., and Cuthbert J.A. Regulatory effects of n-3 polyunsaturated fatty acids on hepatic LDL uptake in the hamster and rat. J. Lipid Res. 36 (1995) 1009-1020
28. Surette M.E., Whelan J., Lu G.P., Broughton K.S., and Kinsella J.E. Dependence on dietary cholesterol for n-3 polyunsaturated fatty acid-induced changes in plasma cholesterol in the Syrian hamster. J. Lipid Res. 33 (1992) 263-271
29. Lin M.H., Lu S.C., Huang P.C., Liu Y.C., and Liu S.Y. The amount of dietary cholesterol changes the mode of effects of (n-3) polyunsaturated fatty acid on lipoprotein cholesterol in hamsters. Ann. Nutr. Metab. 48 (2004) 321-328
30. German J.B., and Dillard C.J. Saturated fats: what dietary intake?. Am. J. Clin. Nutr. 80 (2004) 550-559
31. Kris-Etherton P.M., Harris W.S., and Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 23 (2003) e20-e30
32. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
33. Crestani M., Galli G., and Chiang J.Y. Genomic cloning, sequencing, and analysis of the hamster cholesterol 7 alpha-hydroxylase gene (CYP7). Arch. Biochem. Biophys. 306 (1993) 451-460
34. Lovgren-Sandblom A., Heverin M., Larsson H., Lundstrom E., Wahren J., Diczfalusy U., and Bjorkhem I. Novel LC-MS/MS method for assay of 7alpha-hydroxy-4-cholesten-3-one in human plasma. Evidence for a significant extrahepatic metabolism. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 856 (2007) 15-19
35. Lund E., Sisfontes L., Reihner E., and Bjorkhem I. Determination of serum levels of unesterified lathosterol by isotope dilution-mass spectrometry. Scand. J. Clin. Lab. Invest. 49 (1989) 165-171
36. Dzeletovic S., Breuer O., Lund E., and Diczfalusy U. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 225 (1995) 73-80
37. Heverin M., Bogdanovic N., Lutjohann D., Bayer T., Pikuleva I., Bretillon L., Diczfalusy U., Winblad B., and Bjorkhem I. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J. Lipid Res. 45 (2004) 186-193
38. Ramirez D.M., Andersson S., and Russell D.W. Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain. J. Comp. Neurol. 507 (2008) 1676-1693
39. Lee J.W., Fuda H., Javitt N.B., Strott C.A., and Rodriguez I.R. Expression and localization of sterol 27-hydroxylase (CYP27A1) in monkey retina. Exp. Eye Res. 83 (2006) 465-469
40. Bretillon L., Diczfalusy U., Bjorkhem I., Maire M.A., Martine L., Joffre C., Acar N., Bron A., and Creuzot-Garcher C. Cholesterol-24 S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina. Curr. Eye Res. 32 (2007) 361-366
41. Axelson M., Bjorkhem I., Reihner E., and Einarsson K. The plasma level of 7 alpha-hydroxy-4-cholesten-3-one reflects the activity of hepatic cholesterol 7 alpha-hydroxylase in man. FEBS Lett. 284 (1991) 216-218
42. Eusufzai S., Axelson M., Angelin B., and Einarsson K. Serum 7 alpha-hydroxy-4-cholesten-3-one concentrations in the evaluation of bile acid malabsorption in patients with diarrhoea: correlation to SeHCAT test. Gut 34 (1993) 698-701
43. Sauter G.H., Munzing W., von Ritter C., and Paumgartner G. Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum. Dig. Dis. Sci. 44 (1999) 14-19
44. Galman C., Arvidsson I., Angelin B., and Rudling M. Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood. J. Lipid Res. 44 (2003) 859-866
45. Bjorkhem I., Reihner E., Angelin B., Ewerth S., Akerlund J.E., and Einarsson K. On the possible use of the serum level of 7 alpha-hydroxycholesterol as a marker for increased activity of the cholesterol 7 alpha-hydroxylase in humans. J. Lipid Res. 28 (1987) 889-894
46. Einarsson K., Angelin B., Ewerth S., Nilsell K., and Bjorkhem I. Bile acid synthesis in man: assay of hepatic microsomal cholesterol 7 alpha-hydroxylase activity by isotope dilution-mass spectrometry. J. Lipid Res. 27 (1986) 82-88
47. Kempen H.J., Glatz J.F., Gevers Leuven J.A., van der Voort H.A., and Katan M.B. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J. Lipid Res. 29 (1988) 1149-1155
48. Noshiro M., Nishimoto M., and Okuda K. Rat liver cholesterol 7 alpha-hydroxylase. Pretranslational regulation for circadian rhythm. J. Biol. Chem. 265 (1990) 10036-10041
49. Dietschy J.M., and Turley S.D. Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 12 (2001) 105-112
50. Kris-Etherton P.M., Hecker K.D., and Binkoski A.E. Polyunsaturated fatty acids and cardiovascular health. Nutr. Rev. 62 (2004) 414-426
51. Harris W.S., Park Y., and Isley W.L. Cardiovascular disease and long-chain omega-3 fatty acids. Curr. Opin. Lipidol. 14 (2003) 9-14
52. Kris-Etherton P.M., Harris W.S., and Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106 (2002) 2747-2757
53. Harris W.S. n-3 fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 65 (1997) 1645S-1654S
54. Harris W.S. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J. Lipid Res. 30 (1989) 785-807
55. Herold P.M., and Kinsella J.E. Fish oil consumption and decreased risk of cardiovascular disease: a comparison of findings from animal and human feeding trials. Am. J. Clin. Nutr. 43 (1986) 566-598
56. Nestel P.J. Effects of N-3 fatty acids on lipid metabolism. Annu. Rev. Nutr. 10 (1990) 149-167
57. Ordovas J.M., and Corella D. Genetic variation and lipid metabolism: modulation by dietary factors. Curr. Cardiol. Rep. 7 (2005) 480-486
58. Nicolau V.A., Shefer S., Salen G., and Mosbach E.H. Determination of hepatic cholesterol 7a-hydroxylase activity in man. J. Lipid Res. 15 (1974) 146-151
59. Reihner E., Angelin B., Rudling M., Ewerth S., Bjorkhem I., and Einarsson K. Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients. J. Lipid Res. 31 (1990) 2219-2226
60. Oda H., Yamashita H., Kosahara K., Kuroki S., and Nakayama F. Esterified and total 7 alpha-hydroxycholesterol in human serum as an indicator for hepatic bile acid synthesis. J. Lipid Res. 31 (1990) 2209-2218
61. Russell D.W. 50 years of advances in bile acid synthesis and metabolism. J. Lipid Res. (2008) S120-S125
62. Horton J.D., Cuthbert J.A., and Spady D.K. Regulation of hepatic 7 alpha-hydroxylase expression and response to dietary cholesterol in the rat and hamster. J. Biol. Chem. 270 (1995) 5381-5387
63. De Fabiani E., Crestani M., Marrapodi M., Pinelli A., Chiang J.Y., and Galli G. Regulation of the hamster cholesterol 7 alpha-hydroxylase gene (CYP7A): prevalence of negative over positive transcriptional control. Biochem. Biophys. Res. Commun. 226 (1996) 663-671
64. Gupta S., Pandak W.M., and Hylemon P.B. LXR alpha is the dominant regulator of CYP7A1 transcription. Biochem. Biophys. Res. Commun. 293 (2002) 338-343
65. Chico Y., Fresnedo O., Lacort M., and Ochoa B. Effect of estradiol and progesterone on cholesterol 7 alpha-hydroxylase activity in rats subjected to different feeding conditions. Steroids 59 (1994) 528-535
66. Kajinami K., Brousseau M.E., Ordovas J.M., and Schaefer E.J. Interactions between common genetic polymorphisms in ABCG5/G8 and CYP7A1 on LDL cholesterol-lowering response to atorvastatin. Atherosclerosis 175 (2004) 287-293
67. Kajinami K., Brousseau M.E., Ordovas J.M., and Schaefer E.J. A promoter polymorphism in cholesterol 7alpha-hydroxylase interacts with apolipoprotein E genotype in the LDL-lowering response to atorvastatin. Atherosclerosis 180 (2005) 407-415
68. Meir K., Kitsberg D., Alkalay I., Szafer F., Rosen H., Shpitzen S., Avi L.B., Staels B., Fievet C., Meiner V., Bjorkhem I., and Leitersdorf E. Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasis. J. Biol. Chem. 277 (2002) 34036-34041
69. Ohyama Y., Meaney S., Heverin M., Ekstrom L., Brafman A., Shafir M., Andersson U., Olin M., Eggertsen G., Diczfalusy U., Feinstein E., and Bjorkhem I. Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatory axes. J. Biol. Chem. 281 (2006) 3810-3820
70. Milagre I., Nunes M.J., Gama M.J., Silva R.F., Pascussi J.M., Lechner M.C., and Rodrigues E. Transcriptional regulation of the human CYP46A1 brain-specific expression by Sp transcription factors. J. Neurochem. 106 (2008) 835-849
71. Shafaati M., O'Driscoll R., Bjorkhem I., and Meaney S. Transcriptional regulation of cholesterol 24-hydroxylase by histone deacetylase inhibitors. Biochem. Biophys. Res. Commun. 378 (2009) 689-694
72. Kalmijn S., Launer L.J., Ott A., Witteman J.C., Hofman A., and Breteler M.M. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann. Neurol. 42 (1997) 776-782
73. Kalmijn S., Feskens E.J., Launer L.J., and Kromhout D. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am. J. Epidemiol. 145 (1997) 33-41
74. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Bennett D.A., Wilson R.S., Aggarwal N., and Schneider J. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch. Neurol. 60 (2003) 940-946
75. Schaefer E.J., Bongard V., Beiser A.S., Lamon-Fava S., Robins S.J., Au R., Tucker K.L., Kyle D.J., Wilson P.W., and Wolf P.A. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch. Neurol. 63 (2006) 1545-1550
76. Barberger-Gateau P., Raffaitin C., Letenneur L., Berr C., Tzourio C., Dartigues J.F., and Alperovitch A. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 69 (2007) 1921-1930
77. Larrieu S., Letenneur L., Helmer C., Dartigues J.F., and Barberger-Gateau P. Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort. J. Nutr. Health Aging 8 (2004) 150-154